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Abstract
Background: Perceived beliefs about breast cancer and breast cancer screening are important predictors for
mammography utilization. This study adapted and validated the Champion’s scale in Peru. This scale measures
perceived susceptibility for breast cancer and perceived benefits and barriers for mammography.
Methods: A cross-sectional study was conducted among women ages 40 to 65 attending outpatient gynecology
services in a public hospital in Peru. A group of experts developed and pre-tested a Spanish version of the
Champion’s scale to assess its comprehensibility (N = 20). Factor analysis, internal consistency, and test-retest
reliability analyses were performed (N = 285). Concurrent validity compared scores from participants who had a
mammogram and those who did not have it in the previous 15 months. T-test and multiple regression analysis
adjusting for socio-demographic factors, mammography knowledge and other preventive behaviors were
performed.
Results: The construct validity and reliability were optimal. Cronbach-Alpha coefficients were 0.75 (susceptibility),
0.72 (benefits) and 0.86 (barriers). Concurrent validity analysis showed an association between barriers and
mammography screening use in bivariate (22.3 ± 6.7 vs. 30.2 ± 7.6; p < 0.001) and multiple regression analysis (OR
= 0.28, 95% CI = 0.18-0.43). Ages 50-60 years (OR = 2.35, 95% CI = 1.19-4.65), history of prior Papanicolaou test (OR
= 3.69, 95% CI = 1.84-7.40), and knowledge about breast cancer and mammography (OR = 3.69, 95% CI = 1.84-
7.40) were also independently associated with mammography screening use.
Conclusion: Concurrent validity analysis showed that the Champion’s scale has important limitations for assessing
perceived susceptibility for breast cancer and perceived benefits for mammography among Peruvian women.
There is still a need for developing valid and reliable instruments for measuring perceived beliefs about breast
cancer and mammography screening among Peruvian women.
Background
Breast cancer is the most common malignancy in
women worldwide [1]. In Peru, it is estimated that one
in every 25 women will develop breast cancer during
their lifetimes causing ~1,000 deaths annually just in
Lima, the capital city of Peru [2]. In contrast to the
decline in mortality associated with the successful
implementation of screening programs for early detec-
tion of uterine cervical cancer in Peru [2,3], the efforts
to reduce breast cancer morbidity and mortality are still
insufficient and represent a public health challenge in
this country [4].
Mammography screening decreases breast cancer
mortality by 16% [5-7]. The American Society of Cancer
recommends yearly mammograms starting at age 40 [8].
In Peru, breast cancer screening programs have been
implemented following this recommendation. However,
prior reports have shown that mammography utilization
in Peru is limited. For example, a survey conducted
along the northern coast of Peru revealed that only 16%
of women older than 40 had received a mammogram at
least once in their lifetime [9]. Moreover, less than half
of these women were compliant with annual mammo-
graphy screening [10]. The cost of screening
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for uninsured women, who represent half of the coun-
try’s female population. Mammograms are considered
expensive, especially among the poor and very poor
groups that have an average monthly income of ~80
dollars and represent about a third of the Peruvian
population [11]. Insured and uninsured women in Peru
can access mammograms through public and private
clinics via providers’ referral or through local diagnostic
centers that offer screening without a physician’s order.
Several factors are associated with the practice of
mammography screening [12,13]. In addition to socioe-
conomic conditions and accessibility to health care, stu-
dies have shown that perceived beliefs about breast
cancer and breast cancer screening are independent pre-
dictors of mammography compliance [14,15]. Thus, per-
ceived benefits and barriers to mammography screening
have been explored in diversee t h n i cp o p u l a t i o n su s i n g
the Health Belief Model (HBM) as a framework [16,17].
Among Hispanic populations, for instance, there is a
common belief that cancer is an embarrassing and fatal
disease which causes fear of its diagnosis [18,19]. In
addition, Hispanic women have a very low perceived
susceptibility to breast cancer that leads to poor compli-
ance with screening programs [20]. These beliefs have
not been explored in Peru, in part due to lack of instru-
ments locally validated for this aim.
In 1984, Champion validated a scale to measure per-
ceived susceptibility to breast cancer as well as benefits
and barriers to breast cancer screening behaviors [21]. A
revised version of this scale was published in 1999
showing a significant correlation between mammogra-
phy compliance and high scores in the susceptibility and
benefit subscales; whereas perceived barriers were asso-
ciated with a lower frequency of mammography utiliza-
tion. The scale was validated in a population of
Caucasians (68%) and African-Americans (30%) with
almost no Hispanic or other ethnicities included. The
scale accounted for 54% of the variance and showed
adequate construct validity and reliability [22].
The aim of our study was to validate a Spanish-trans-
lated version of the 1999 revised Champion’ss c a l et o
measure beliefs about breast cancer and mammography
screening in Peruvian women. Ultimately, concurrent
validity analysis was performed to determine if the scale
was associated with recent mammography screening
utilization.
Methods
Study design and participants
A cross-sectional study was conducted in women aged
40 to 65 years who attended an outpatient gynecology
clinic at Hospital Nacional Arzobispo Loayza, a large
tertiary care public hospital in Lima, Peru. It excluded
women with prior history of breast cancer or breast
surgery, women who sought care due to breast related
illness, and those with history of breast cancer in a
first degree relative. Eligible women were informed
about the study and signed a consent form prior to
participation. Sample size was calculated based on
expected differences in scale scores between women
who had received a screening mammogram in the
prior 15 months and those who had not. Thus, at least
253 participants were needed to obtain a difference of
at least 0.96 on the susceptibility subscale (the subscale
with the smallest expected difference according to ori-
ginal validation study [22]) using alpha error 0.05 and
beta error 0.20.
The scale
The 1999 revised Champion’s scale has 19 items distrib-
uted in three different dimensions (subscales): suscept-
ibility (3 items), benefits (5 items), and barriers (11
items). Each item was anchored with a five-point Likert
scale with response options from 1="strongly disagree”
to 5="strongly agree”. The scale was originally validated
in a cohort of 804 women age 50 or over who were
members of a Health Maintenance Organization (HMO)
in Indiana, US. Sixty-eight percent were Caucasians and
30% were African-Americans. The other 2% were Asian,
Hispanic or Native American [22]. The Champion’s
scale has been mostly used in the US as a research tool
to study the beliefs about breast cancer screening in dif-
ferent populations [23,24] and to develop interventions
to improve the utilization of mammography [25]. Multi-
ple adaptations have been validated for other popula-
tions around the globe [26-28]. More recently, a Spanish
version of the scale was adapted and tested in a cohort
of 274 women in Spain [29].
The English [22] and Spanish [29] versions of the
Champion’s scale were revised by the authors of the
study and four bilingual experts. We found minor gram-
matical and semantic discrepancies in certain items
(item 2, 4, 5, 6, 7, 11, 13, 15, 17) that were adapted to
local dialect by consensus. A pilot study was conducted
in 20 women to ensure understanding of all items. No
further modifications to the scale were required as a
result of the pilot study. The time for scale completion
had a median of 12 minutes.
Procedures
The scale was administered to all eligible women who
accepted to participate in the study. Illiterate partici-
pants provided their answers via direct interview. Socio-
demographic data was collected from each participant.
Participants also answered a questionnaire of knowledge
about breast cancer and mammography. This question-
naire was based on an instrument previously validated
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prevention in Peru [10].
Validation of the scale
Construct validity, reliability and concurrent validity of
the scale were evaluated using Stata v10.0. To evaluate
construct validity we used exploratory factor analysis
(EFA) with a viramax rotation. In this analysis we looked
for different factors (dimensions) in the scale. Factor
extraction was guided by theory and eigenvalues. Items
with loading factors above 0.4 were retained in their cor-
responding factor. Confirmatory factor analysis (CFA)
using LISREL [30,31] was conducted to confirm relation-
ships established by the EFA. Thus, a covariance matrix
of the 19 items was used as an input in testing the model.
The fit of the model to the data was evaluated using
Goodness of Fit Index (GFI), which was expected to be
close to 0.9 as suggested by Boyd et al [32].
Reliability was evaluated using Cronbach-Alpha and
test-retest correlation. Each dimension was expected to
have an alpha of at least 0.7. If a dimension’sa l p h a
increased more than 0.1 after an item had been elimi-
nated, this item was removed from the scale. Items were
also removed if the score of the item and its dimension
had a correlation lower than 0.3 after the item was
excluded. For test-retest correlation we randomly
selected 30 participants to complete the scale 21 to 28
days after the participant had completed the scale for
the first time. We compared the test-retest scores for
each dimension using Pearson correlation test. We con-
sidered that test-retest correlation coefficient should be
at least 0.6.
Concurrent validity was evaluated comparing the sub-
scale scores of women who had received a mammogram
in the last 15 months with those who had not received a
mammogram in the last 15 months, using the t-student
test. Finally, we used logistic regression models to adjust
the association between the subscale scores and mam-
mogram utilization. The three subscale scores were
entered into the model as independent factors. For this,
we generated scores from each subscale with the Stata
command “predict”. The model was adjusted by socio-
economic variables, data collection methodology, other
preventive behaviors, and knowledge about breast can-
cer and mammography. The variables that were
included in the final model were: perceived susceptibility
score, perceived benefits score, perceived barriers score,
age (40-to-50, 50-60, 60-to-65 years), region of birth
(coast, highlands, jungle), region of current residence
(coast, highlands, jungle), formal education (none/ele-
mentary, high school, university), the method of data
collection (self-administered questionnaire vs. direct
interview), the history of Papanicolaou test in the last 15
months, the history of breast self-exams in the last 6
months. We report odds ratios (OR) at 95% confidence
interval. P-values less than 0.05 were considered as sta-
tistically significant.
Ethical aspects
This study was approved by the Research Unit of Hospi-
tal Nacional Arzobispo Loayza and the Ethics Commit-
tee of Universidad Peruana Cayetano Heredia. Personnel
from the US Naval Medical Research Unit 6 (NAMRU-
6) in Peru helped with data analysis and manuscript
edition.
Results
Between May and June 2008, 296 women completed the
scale. Two hundred eighty-five women (96.3%) provided
complete data and were included in the analysis, 37.2%
had received a screening mammogram in the prior 15
months, and 57.2% reported to have had a screening
mammogram at least once during their lifetime. The
socio-demographic characteristics of the participants are
shown in table 1.
In the EFA we identified three dimensions (subscales)
that overall accounted for 48% of the variance. Each of
the three dimensions extracted from the EFA had eigen-
values higher than 1 and corresponded to the dimen-
sions of barriers, benefits and susceptibilities of the 1999
revised Champion’s scale (table 2). Confirmatory factor
analysis supported the results of EFA. The Goodness of
Fit Index for these data was 0.89.
All the items had factor loadings above 0.4 in their
corresponding dimensions as shown in table 2. Factor 1
which corresponds to perceived barriers had items with
loadings between 0.60 and 0.70. Factor 2 which corre-
sponds to perceived benefits had items with loadings
between 0.50 and 0.76. Factor 3 which corresponds to
perceived susceptibility had items with loading factors
between 0.79 and 0.81. After loading in their primary
dimension, none of the items had factor loadings above
0.3 in any other dimension which indicates that the
items did not overlap dimensions. Standardized factor
loadings in CFA were also above 0.4 for each item in its
corresponding dimension.
In terms of reliability (table 3), the susceptibility
dimension had an alpha of 0.75 with no increase greater
than 0.1 after eliminating any items. The item-to-dimen-
sion scores correlation was between 0.56 and 0.63. The
benefits dimension had an alpha of 0.72 with no
increase greater than 0.1 after eliminating any items.
The item-to-dimension scores correlation was between
0.31 and 0.62. Perceived barriers had an alpha of 0.86.
Item-to-dimension scores correlation was high, between
0.84 and 0.85. Test-retest scores for the three dimen-
sions had Pearson correlation coefficients higher than
0.6 (table 3).
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tion between subscales scores and mammography
screening in the prior 15 months are shown in table 4.
Perceived barriers had significantly lower scores among
women who had received a mammogram in the prior
15 months (p < 0.001). In addition, lower barrier scores
were found among those with university degrees in
comparison to those with high school (p < 0.001) and
elementary school/no formal education (p < 0.001). Per-
ceived benefits and susceptibility scores were not asso-
ciated with mammography screening, formal education
level, or age.
Multiple logistic regression analysis showed that per-
ceived barriers were strongly associated with mammo-
graphy screening even after adjusting by all the other
variables (OR = 0.28 for each additional point in the
score, 95%CI 0.18-0.43; p < 0.001). Other factors asso-
ciated with mammography screening were age between
50 and 60 years (OR = 2.35, 95%CI 1.19-4.65; p =
0.014), knowledge about breast cancer and screening
mammogram (mid tercile, OR = 2.18, CI95% 1.09-4.39;
p = 0.028; upper tercile, OR = 2.55, CI95% 1.14-2.73; p
= 0.023), and history of Papanicolaou test in the prior
15 months (OR = 3.69, CI95% 1.84-7.40; p < 0.001;
table 5).
Discussion
Our findings reveal that a Spanish-adapted version of
the Champion’s scale applied in Peruvian women had
optimal construct validity and reliability. Moreover, the
completeness of the scale was high (96.3% of partici-
pants answered all the questions) which indicates that
this instrument was easy and simple to administer.
However, the scale had significant limitations in terms
of concurrent validity. Perceived barriers was the only
subscale associated with recent mammography screening
in both bivariate and multivariate analysis. Neither per-
ceived susceptibilities nor benefits were associated with
recent mammography screening.
Based on the health belief model as a conceptual fra-
mework, studies have demonstrated that beliefs about
breast cancer and mammography screening are impor-
tant predictors of mammography compliance [15,16]. It
follows that a scale exploring these beliefs should be
able to distinguish between women who had received a
mammogram from those who had not received a mam-
mogram. In the original validation study, the three
Table 1 Participants’ socio-demographic characteristics
Characteristics n %
Age (media ± SD
a, 50.2 ± 6.8)
40 to 50 years 145 50.8
50 to 60 years 106 37.2
60 to 65 years 34 11.9
Region of current residence
Lima 257 90.4
Coast (other than Lima) 269 94.4
Highlands 15 5.2
Jungle 1 0.4
Level of formal education
None/incomplete elementary school 41 14.6
Completed elementary school 38 13.6
Incomplete high school 52 18.6
Completed high school 84 30.0
Incomplete university education 28 10.0
Completed university education 37 13.2
Mammogram in the prior 15 months
Yes 106 37.2
No 179 62.8
Breast self-exam in the prior 6 months
Yes 201 71.0
No 84 29.0
Papanicolaou test in the prior 15 months
Yes 191 68.0
No 94 32.0
Scores for each scale dimension
b (media ± SD)
Susceptibilities 9.5 ± 2.7
Benefits 18.9 ± 3.6
Barriers 27.3 ± 8.2
a SD = standard deviation
b possible ranges of scores: susceptibilities (3-15), benefits (5-25), barriers (11-
55)
Table 2 Results of exploratory factor analysis with
viramax rotation
Items Factor 1 Factor 2 Factor 3
SUS1 0.79
SUS2 0.81
SUS3 0.80
BEN1 0.50
BEN2 0.81
BEN3 0.63
BEN4 0.76
BEN5 0.75
BAR1 0.65
BAR2 0.70
BAR3 0.65
BAR4 0.65
BAR5 0.61
BAR6 0.64
BAR7 0.65
BAR8 0.62
BAR9 0.64
BAR10 0.60
BAR11 0.66
Eigenvalue 4.61 2.56 2.1
SUS = susceptibilities; BEN = benefits; BAR = barriers.
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with screening mammography utilization among women
from a US city [22]. Although the scale was successfully
adapted and validated in Turkey Jordan and Malaysia
[26,27], a Spanish-translated version showed important
limitations in terms of predictive validity and construct
validity when administered in Spain [29]. In our study,
although perceived barriers had similar psychometric
properties to the original version of the scale, its other
components (susceptibilities and benefits) showed poor
concurrent validity. Therefore, we consider that this
instrument should not be used among Peruvian women.
An explanation of our findings might be that the
Champion’s scale does not include beliefs about breast
cancer and screening mammography that are particu-
larly important for Peruvian women. Therefore, the con-
tent of this scale should be reviewed and modified based
on qualitative research including interview and focal
group techniques with special emphasis on perceived
susceptibilities and benefits. Once negative attributes
and misconceptions related to poor mammography
compliance are identified, targeted interventions could
be implemented to promote breast cancer screening in
Peru. As demonstrated in a meta-analysis of Yabroff et
al, interventions directed to modify negative beliefs
improve mammography utilization in 24%; even more
effective than phone calls, letter reminders or interven-
tions based on sociologic theories [33]. It is also possible
that differences in demographics between our popula-
tion and the Champion’s cohort could have contributed
to our results. In the Champion’s study, women were 50
years or more with a mean of 61 and had a high mean
educational level (12.5 years). In our study, we included
women aged 40 or more with a mean of 50. More than
Table 3 Reliability of the scale (n = 30 for test-retest correlation coefficient)
ITEM Item-total correlation Cronbach Alpha Cronbach Alpha if item is eliminated Test-retest correlation coefficient
SUS1 0.56 0.69
SUS2 0.62 0.62
SUS3 0.56 0.79
Total susceptibility 0.75 0.87; p < 0.001
BEN1 0.31 0.76
BEN2 0.62 0.63
BEN3 0.43 0.70
BEN4 0.58 0.64
BEN5 0.55 0.65
Total benefits 0.72 0.61; p < 0.001
BAR1 0.57 0.85
BAR2 0.63 0.84
BAR3 0.57 0.84
BAR4 0.55 0.85
BAR5 0.52 0.85
BAR6 0.56 0.85
BAR7 0.57 0.85
BAR8 0.55 0.85
BAR9 0.54 0.85
BAR10 0.51 0.85
BAR11 0.55 0.85
Total barriers 0.86 0.94; p < 0.001
Table 4 Scores for each scale dimension by
mammography use, age and education.
Susceptibility
a Benefits
a Barriers
a
Screening mammogram
Yes 9.2 ± 2.7 19.2 ± 3.5 22.3 ± 6.7
No 9.8 ± 2.6 18.9 ± 3.7 30.2 ± 7.6
p = 0.071
b p = 0.565
b p=<0.001
b
Age
40 to 50 years 9.8 ± 2.8 19.1 ± 4.0 16.9 ± 8.3
50 to 60 years 9.4 ± 2.5 19.0 ± 2.8 28.0 ± 8.0
60 to 65 years 9.4 ± 2.5 18.7 ± 4.1 26.5 ± 9.0
p = 0.477
c p = 0.844
c p = 0.4773
c
Education
None/elementary school 9.9 ± 2.7 19.0 ± 3.0 30.9 ± 6.6
High school 9.5 ± 2.7 19.1 ± 3.8 27.1 ± 8.4
University degree 9.3 ± 2.7 19.0 ± 3.7 22.6 ± 6.9
p = 0.348
c p = 0.956
c p=<0.001
c
a possible ranges of scores: susceptibilities (3-15), benefits (5-25), barriers (11-
55)
b t-student test
c ANOVA test
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cation. Moreover, 49% of our sample were interviewed
whereas in the Champion’s study the scale was only
self-administered as those not able to read or write
were excluded. Finally, differences in the study design
could have contributed to discrepancies between our
study and the Champion’s study. The later study evalu-
ated the completion of mammogram screening after
the baseline assessment of the scale (predictive valid-
ity). Our study assessed the scale and mammography
utilization at the same time (concurrent validity). In
certain circumstances, having a recently negative mam-
mogram could have reinforced the belief that one is
n o ts u s c e p t i b l et ob r e a s tc a n c e ro rt h a tt h e r ew a sn o
benefit from having the screening, especially among
the younger participants.
Our findings suggest that the Champion’s scale should
be applied with caution in populations with high pro-
portion of Hispanic women. Although our results might
not be generalizable to other Hispanic populations,
common beliefs about mammography screening may be
shared in the region making possible some extrapolation
of these results [16]. Previous investigations have shown
that most Hispanic women believe that cancer is a fatal
illness which generates fear of cancer diagnosis [18,19].
Other barriers include those directly related to the exam
technique such as considering mammogram uncomfor-
table and embarrassing. In addition, Hispanic women
consider that breast cancer is a severe illness; however,
their own perceived susceptibility to the illness is very
low and find scant benefit in regular mammography
screening [20]. Recently, Medina-Shepard et al reported
high construct validity and reliability of a similar Span-
ish-translated version of the Champion’s scale in a His-
panic cohort from South Florida; but no concurrent or
predictive validity analysis was performed [23]. Borrayo
et al. have developed a scale for beliefs about breast can-
cer and mammography screening for Hispanic women
validated in a different US city. Although the scale
showed strong construct validity, reliability and predic-
tive validity; it has 6 dimensions and 35 items, which
might be a limitation for its application in non-research
settings, particularly in resource limited areas with a
high proportion of illiterate women who require addi-
tional personnel to complete the scale. Further research
in scale development for breast cancer screening in our
region is needed [34].
Logistic regression analysis allowed us to identify
other factors associated with mammography screening.
Women aged 50 to 60 years had higher rates of mam-
mogram utilization in comparison to those aged 40 to
50 years. Although age is associated with other preven-
tive behaviors such as uterine cervical cancer screen-
ing [12], prior studies have reported inconsistent
associations between mammography screening and
age [12,35,36]. In our sample, the very poor mammogra-
phy compliance in younger women might be in part due
to lack of knowledge about current screening recom-
mendations. Nevertheless, a proportional increase of
mammogram utilization was expected among women
above 60 years which was not observed in our data.
Investigations exploring awareness of current breast
cancer guidelines among health care providers are also
recommended to determine if practice guidelines need
to be reinforced among health care personnel in these
settings. Knowledge about breast cancer and mammo-
grams as well as history of recent Papanicolaou tests
were associated with mammography screening which
Table 5 Factors associated with screening mammography
in logistic regression analysis
Crude Odds
Ratio
OR (95% CI)
Adjusted Odds
Ratio
OR (95% CI)
a
Scale dimensions
Susceptibilility 0.88 (0.69-1.13) 0.84 (0.63-1.14)
Benefits 1.13 (0.88-1.46) 1.18 (0.86-1.60)
c
Barriers 0.29 (0.21-0.41) 0.28 (0.19-0.43)
Age
40 to 50 years
b –
50 to 60 years 1.60 (0.96-2.70) 2.35 (1.19-4.65)
60 to 65 years 0.97 (0.43-2.15) 0.91 (0.33-2.46)
Formal education
None/elementary
school
b
–
High school 2.07 (1.12-3.80) 1.31 (0.59-2.87)
University education 2.38 (1.17-4.81) 0.91 (0.34-2.43)
Region of birth
Coast
b –
Highlands 0.70 (0.43-1.15) 1.31(0.66-2.60)
Jungle 0.71 (0.21-2.49) 0.53(0.11-2.54)
Region of current residence
Coast
b –
Highlands 0.59 (0.15-1.92) 0.36(0.08-1.67)
Jungle
d –
Knowledge
Lower tercile
b –
Middle tercile 2.46 (1.4-4.33) 2.18(1.09-4.39)
c
Upper tercile 3.28 (1.70-6.32) 2.55(1.14-2.73)
c
Self breast exam 1.59 (0.92-2.75) 0.88(0.43-1.80)
Papanicolaou test 2.96 (1.67-5.23) 3.69(1.84-7.40)
c
Data collection
methodology
Self-administered
b –
Direct interview 0.78 (0.48-1.26) 0.94(0.47-1.88)
a Odds ratio (OR) adjusted by all the other variables in the model.
b Reference category.
c Statistically significant association.
d Dropped from the model, only one participant was living in Jungle region.
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dies [35,37]. Future interventions to promote mammo-
graphy utilization in our region should also address this
lack of information about breast cancer and screening
methods.
This study had some limitations. The history of having
received a screening mammogram in the prior 15
months was established by self-report. Thereby, this
might have introduced misclassification bias. Partici-
pants had the option to complete a self-administered
scale or provide their answers via interview. This dual
data collection methodology was needed as almost half
of our participants were illiterate. This could have intro-
duced a detection bias among women who were inter-
viewed; however, logistic regression analysis showed no
significant association between screening mammogram
compliance and data collection methodology. Finally, it
is important to consider that several studies have shown
that health care accessibility is one of the most impor-
tant factors influencing mammography utilization [35,37].
Our study population included women who attended a
gynecology clinic therefore already bypassed the access
barrier. This might explain the relatively high rate of
recent mammogram utilization in our group (37%) in
comparison to similar reports in Peru [9,10]. Thereby,
our study population might not necessarily be a repre-
sentative sample of Peruvian women. Community-based
studies are recommended to explore the beliefs about
screening mammogram among those who do not routi-
nely access medical care.
Conclusions
In summary, although the adapted version of the Cham-
pion’s scale was simple and had optimal construct valid-
ity and reliability; concurrent validity analysis showed
that the scale has limitations for assessing perceived sus-
ceptibility for breast cancer and perceived benefits for
mammography among Peruvian women. Our findings
suggest that this scale should not be used among Peru-
vian women until further content review. Further
research to develop alternative instruments based on the
health belief model is recommended.
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